title: Carbimazole therapy in the setting of end-stage renal disease and haemodialysis.
authors.affiliation: Department of Endocrinology, University Hospital of North Staffordshire, Stoke-on-Trent ST4 6QG, UK. georgeiv@doctors.org.uk
authors.forename: George I
authors.initials: GI
authors.lastname: Varughese
authors.forename: Abd A
authors.initials: AA
authors.lastname: Tahrani
authors.forename: Jen L
authors.initials: JL
authors.lastname: Smith
authors.forename: Richard N
authors.initials: RN
authors.lastname: Clayton
authors.forename: Fahmy W
authors.initials: FW
authors.lastname: Hanna
mesh_terms: D000138:Acidosis / Q000150:complications; D000328:Adult; D013956:Antithyroid Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000209:etiology; D001711:Biotransformation; D002231:Carbimazole / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004058:Diffusion; D004334:Drug Administration Schedule; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008713:Methimazole / Q000493:pharmacokinetics; D011355:Prodrugs / Q000008:administration & dosage* / Q000493:pharmacokinetics / Q000627:therapeutic use; D006435:Renal Dialysis
chemical_list: D013956:Antithyroid Agents; D011355:Prodrugs; D008713:Methimazole; D002231:Carbimazole